Clinical Trial Update: DMT310-003 Topical in the Treatment of Acne Vulgaris [Phase 2]

View source ↗

Summary

Phase 2 trial update for DMT310-003 topical treatment in acne vulgaris has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• DMT310-003

Snippet

Sponsor: Dermata Therapeutics | Conditions: Acne Vulgaris | Phase 2 | Status: COMPLETED